Literature DB >> 35488027

A longitudinal pilot study to assess temporal changes in coronary arterial 18F-sodium fluoride uptake.

Toshiro Kitagawa1, Ko Sasaki2, Yuto Fujii3, Fuminari Tatsugami4, Kazuo Awai4, Yutaka Hirokawa2, Yukiko Nakano3.   

Abstract

PURPOSE: How coronary arterial 18F-sodium fluoride (18F-NaF) uptake on positron emission tomography changes over the long term and what clinical factors impact the changes remain unclear. We sought to investigate the topics in this study.
METHODS: We retrospectively studied 15 patients with ≥1 coronary atherosclerotic lesion/s detected on cardiac computed tomography who underwent baseline and follow-up (interval of >3 years) 18F-NaF positron emission tomography/computed tomography scans. Focal 18F-NaF uptake in each lesion was quantified using maximum tissue-to-background ratio (TBRmax). The temporal change in TBRmax was assessed using a ratio of follow-up to baseline TBRmax (R-TBRmax).
RESULTS: A total of 51 lesions were analyzed. Mean R-TBRmax was 0.96 ± 0.21. CT-based lesion features (location, obstructive stenosis, plaque types, features of high-risk plaque) did not correlate with an increase in R-TBRmax. In multivariate analysis, baseline TBRmax significantly correlated with higher follow-up TBRmax (β = 0.57, P < 0.0001), and the presence of diabetes mellitus significantly correlated with both higher follow-up TBRmax (β = 0.34, P = 0.001) and elevated R-TBRmax (β = 0.40, P = 0.003).
CONCLUSION: Higher coronary arterial 18F-NaF uptake is likely to remain continuously high. Diabetes mellitus affects the long-term increase in coronary arterial 18F-NaF uptake.
© 2022. The Author(s) under exclusive licence to American Society of Nuclear Cardiology.

Entities:  

Keywords:  Atherosclerosis; CAD; Diseases/processes; Modalities; Molecular imaging agents; PET; Tests; Tracers; Vascular imaging

Year:  2022        PMID: 35488027     DOI: 10.1007/s12350-022-02975-w

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  1 in total

1.  [18F]FDG and [18F]NaF as PET markers of systemic atherosclerosis progression: A longitudinal descriptive imaging study in patients with type 2 diabetes mellitus.

Authors:  M Reijrink; S A de Boer; C A Te Velde-Keyzer; J K E Sluiter; R A Pol; H J L Heerspink; M J W Greuter; J L Hillebrands; D J Mulder; R H J A Slart
Journal:  J Nucl Cardiol       Date:  2021-09-13       Impact factor: 3.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.